AA
NKGNW

Ancora Advisors’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Ancora Advisors’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed – – 2080
2022
Q4 		$0 Hold
200
– – ﹤0.01% 2008
2022
Q3 		$0 Hold
200
– – ﹤0.01% 2211
2022
Q2 		$0 Hold
200
– – ﹤0.01% 2371
2022
Q1 		$0 Buy
+200
New +$166 ﹤0.01% 2533

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Ancora Advisors's NKGNW Position: Q1 2023 in Review

Ancora Advisors sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2023, closing a stake of 200 shares.

Ancora Advisors first reported a position in NKGNW in Q1 2022 and held it in 4 quarters. The position peaked at $0 in Q4 2022. 37 funds tracked by Wall St. Rank hold NKGNW as of Q1 2023.

  • Ancora Advisors reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2023 after selling out during the quarter.
  • Ancora Advisors sold 200 NKGen Biotech, Inc. Warrants shares in Q1 2023.
  • Ancora Advisors first reported a position in NKGen Biotech, Inc. Warrants in Q1 2022 and held it in 4 quarters.
  • Ancora Advisors's NKGen Biotech, Inc. Warrants position peaked at $0 in Q4 2022.
  • 37 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.